期刊文献+

广州市番禺区宫颈癌筛查结果分析 被引量:9

Analysis on cervical cancer screening results in Panyu district of Guangzhou city
原文传递
导出
摘要 目的:了解广州市番禺区2000年~2011年12年间全区妇女宫颈癌筛查情况。方法:对辖区适龄妇女进行宫颈细胞学检查,并记录个人信息及病史。结果:共完成宫颈癌筛查119 648例,受检时平均年龄(40.60±3.50)岁,总阳性率为9.92%,2000年筛查阳性率为8.91%,2011年增加至12.02%,其中40岁以下构成比从2000年的43.00%增加到2011年的50.58%,农村妇女阳性率12.76%,城镇妇女阳性率7.42%,筛查出宫颈癌119例,发病率为9.95/万。结论:适龄女性宫颈疾病发病率逐年增高,呈年轻化趋势,农村妇女发病率高于城镇妇女,应普及宫颈癌筛查,加强妇女卫生教育宣传。 Objective: To explore the cervical cancer screening status in Panyu district of Guangzhou city from 2000 to 2011.Methods: Cervical cytologic test was conducted among the women of the right age in Panyu district,the individual information and medical records were recorded.Results: A total of 119 648 women received cervical cancer screening,the mean age was(40.60 ± 3.50) years,the total positive rates was 9.92%,the positive screening rate in 2000 was 8.91%,then it increased to 12.02% in 2011,the proportion of women under 40 years old increased from 43.00% in 2000 to 50.58% in 2011,the positive rated among rural women and urban women were 12.76% and 7.42%,respectively;119 women with cervical cancer were carried out,the prevalence rate was 9.95 /10 000.Conclusion: The incidence rates of cervical diseases among women in the right age increase year by year,which become younger and younger.The incidence rates of cervical diseases in rural women are higher than those in urban women,cervical cancer screening should be popularized,and maternal health education and publicity should be enhanced.
出处 《中国妇幼保健》 CAS 北大核心 2013年第22期3557-3559,共3页 Maternal and Child Health Care of China
基金 广东省医学科研基金资助〔A2010068〕
关键词 宫颈癌 筛查 健康教育 Cervical cancer Screening Health education
  • 相关文献

参考文献13

  • 1Vijayaraghavan A, Efrusy MB, Mayrand MH, et al. Cost - ef- fectiveness of high - risk human papillomavirus testing for cer- vical cancer screening in Quebec, Canada [ J ]. Can J Public Health, 2010, 101 (3) : 220.
  • 2Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010 : a systematic analysis [ J ]. Lancet, 2011, 378 ( 9801 ) : 1461.
  • 3Herbert A, Bergeron C, Wiener H, et al. European guidelines for quality assurance in cervical cancer screening: recommen- dations for cervical cytology terminology [J]. Cytopathology, 2007, 18 (4): 213.
  • 4王红,徐福智,赵秋艳.三阶梯诊疗程序筛查宫颈癌前病变[J].中国妇幼保健,2011,26(5):769-770. 被引量:11
  • 5Datta SD, Saraiya M. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: back- ground paper for 2010 STD treatment guidelines [ J ] . Clin Infect Dis, 2011, 53 (Suppl3) : S153.
  • 6Vidal AC, Murphy SK, Hernandez BY, et al. Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women [ J] . Infect Agent Cancer, 2011, 6 (1): 20.
  • 7孟瑞琳,马文军,许燕君,宋秀玲,聂少萍,徐浩锋,许晓君,蔡秋茂,夏亮.广东省妇女乳腺癌和宫颈癌筛查率及相关影响因素分析[J].华南预防医学,2010,36(2):8-10. 被引量:37
  • 8Basu P, Nessa A, Majid M, et al. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines [J].J Fam Plann Reprod Health Care, 2010, 36 (3) : 131.
  • 9Anttila A, Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screen- ing methods [ J ]. Coll Antropol,2007,31 ( Suppl 2) : 17.
  • 10Mun JY, Han MA, Lee HY, et al. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008 [J] . Asian Pac J Cancer Prev, 2011, 12 (8) : 1961.

二级参考文献36

  • 1李庭芳,陈锐.宫颈癌临床流行病学概述[J].实用医院临床杂志,2005,2(2):19-22. 被引量:62
  • 2GOREY K M, HOLOWARY E J, FEHRINGER G, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas[J]. Am J Public Health, 1997,8(7) : 1156 -1163.
  • 3HOLCOMB K, RUNOWICZ C D. Cervical cancer screening[J]. Surg Oncol Clin N Am, 2005, 14(7): 777-797.
  • 4PARKIN D M, BRAY F, FERLAY J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55( 1 ) :74 - 108.
  • 5丰有吉.妇产科学[M].第2版.北京:人民卫生出版社,2010:68-69.
  • 6Doudja Hammouda, Nubia Muiioz, Rolando Herrero. Cervical carcinoma in Algiers, Algeria: human Papillomavirus and lifestyle risk factors[J]. Int J Cancer, 2005, 113(3):483 - 489.
  • 7Winer RL, Hughes JP, Feng O, et al. Condom use and the risk of genital human papillomavirus infection in young women[J]. N Engl J Med, 2006, 22(25) :2645 - 2654.
  • 8Junej A, Sehgal A, Mitra AB, et al. A survey on risk factors associated withcervical cancer[J]. Indian J Cancer, 2003, 40( 1 ) : 15 - 22.
  • 9Fahey MT, lrwig L, Macaskill P. Metaanalysis of Pap test accuracy Am J Epiderniol, 1995, 141:680 - 689.
  • 10Dai M,Bao YP,Li N,et al. Human papillomavirus infection in Shanxi Province, Peoples Republic of China: a population-based study[J]. Br J Cancer, 2006,95 : 96-101.

共引文献64

同被引文献72

  • 1王临虹,邱琇,郑睿敏,狄江丽.我国宫颈癌流行病学状况及防治策略的回顾与展望[J].中国妇幼卫生杂志,2010,1(3):146-149. 被引量:76
  • 2文海蓉.宫颈癌危险因素研究进展[J].疾病控制杂志,2005,9(5):452-454. 被引量:5
  • 3赵文荣,吴佩军,刘勇,汤光宇.动态增强MRI对肝门型胆管癌的诊断[J].现代医学,2007,35(2):141-144. 被引量:8
  • 4Kim HJ, Sohn BS, Kwon JE, et al. ThinPrep Cytological Find- ings of Desmoplastic Small Round Cell Tumor with Extensive Glandular Differentiation: A Case Study [J] . Korean J Pathol, 2013, 47 (2): 182-187.
  • 5Datta SD, Saraiya M. Cervical cancer screening among women who attend sexually transmitted diseases ( STD ) clinics : back- ground paper for 2010 STD treatment guidelines [ J]. Clin Infect Dis ,2011,53 ( Suppl 3 ) : S153 - S159.
  • 6Shi BJ,Xue M,Liu Y,et al. First report of the coexistence ofdyschromatosis symmetrica hereditaria and psoriasis : one no-vel TCT to A mutation in the double-RNA-specific adenosinedeaminase gene[J], J Eur Acad Dermatol Venereol,2012,26(5):657-658.
  • 7Liu HM,Cheng P,Huang X,et al. Identification of TCT,a novel knockdown resistance allele mutation and analysisof resistance detection methods in the voltage-gated Na(+) channel of Culex pipiens pallens from ShandongProvince,China[J]. Mol Med Rep, 2013 ,7(2) : 525-530.
  • 8Massad LS,Einstein MH,Huh WK,et al.2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J].Obstet Gynecol,2013,121(4):829-846.
  • 9Poliquin V,Decker K,Altman A,et al.Changes in cervical cancer screening behavior for women attending Pap Test Week clinics[J].Int J Womens Health,2013,5(2):141-148.
  • 10Chen H,Shu HM,Chang ZL,et al.Efficacy of Pap test in combination with Thin Prep cytological test in screening for cervical cancer[J].Asian Pac J Cancer Prev,2012,13(4):1651-1655.

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部